ListarINIBIC-ICATC - Artigos por tema "Advanced heart failure"
Mostrando ítems 1-7 de 7
-
A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: an expert panel consensus
(Elsevier, 2019-12-15)[Abstract] Inotropes aim at increasing cardiac output by enhancing cardiac contractility. They constitute the third pharmacological pillar in the treatment of patients with decompensated heart failure, the other two being ... -
Advanced heart failure: definition, epidemiology, and clinical course
(Elsevier, 2021-07-15)[Abstract] Advanced heart failure (HF) is characterized by a progressive worsening of symptoms disabling for daily life, refractory to all therapies, and with high mortality. These patients may be candidates for life-prolonging ... -
Efficacy and safety of intermittent intravenous outpatient administration of levosimendan in patients with advanced heart failure: the LION‐HEART multicentre randomised trial
(Wiley, 2018)[Abstract] Aims. The LION‐HEART study was a multicentre, double‐blind, randomised, parallel‐group, placebo‐controlled trial evaluating the efficacy and safety of intravenous administration of intermittent doses of levosimendan ... -
Guidance on the Management of Left Ventricular Assist Device (LVAD) Supported Patients for the Non-LVAD Specialist Healthcare Provider: Executive Summary
(Wiley, 2021-08-18)[Abstract] The accepted use of left ventricular assist device (LVAD) technology as a good alternative for the treatment of patients with advanced heart failure together with the improved survival of patients on the device ... -
Inotropic therapy in patients with advanced heart failure: a clinical consensus statement from the Heart Failure Association of the European Society of Cardiology
(John Wiley & Sons, 2023-02-27)[Abstract] This clinical consensus statement reviews the use of inotropic support in patients with advanced heart failure. The current guidelines only support use of inotropes in the setting of acute decompensated heart ... -
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use
(Wolters Kluwer, 2020-07)[Abstract] Levosimendan was first approved for clinical use in 2000, when authorization was granted by Swedish regulatory authorities for the hemodynamic stabilization of patients with acutely decompensated chronic heart ... -
Pulmonary vascular remodeling and prognosis in patients evaluated for heart transplantation: insights from the OCTOPUS-CHF study
(MDPI, 2022-12-06)[Abstract] Objective: In patients with advanced heart failure, the intravascular optical coherence tomography (OCT) of subsegmental pulmonary artery measurements is correlated with right heart catheterization parameters. ...